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Abstract
Background: Mammalian spermatozoa become fully motile and fertile during transit through the
luminal fluid of the epididymis. At least 200 proteins are present in the epididymal lumen, but the
potential roles of these luminal proteins in male fertility are unknown. Investigation of the function
of these proteins will elucidate the mechanism of sperm maturation, and also provide new drug
targets for male contraception. We cloned RNase9 from a human epididymis cDNA library for
characterization and analysis of its functions.
Findings: It was predicted that human RNase9 gene was located on chromosome 14q11.2 and
encoded a 205 amino acids protein with a signal peptide of 26 amino acids at the N-terminus. The
protein had eight conserved cysteine residues characteristic of the RNase A family members and
several potential post-translational modification sites.
At the transcriptional level, RNase9 was expressed in a wide variety of tissues, and the expression
was higher in men than in boys. RNase9 was localized to the post-equatorial region of the sperms'
head. Immunofluorescence staining showed that RNase9 protein was present mostly in the
epithelium of the epididymal tubule. Recombinant RNase9 had no ribonuclease activity. In addition,
RNase9 had no detectable effect on sperm motility and fertilization as demonstrated by blocking
spermatozoa with anti-RNase9 polyclonal serum.
Conclusion: RNase9 is expressed in a wide variety of tissues. It is located on the post-equatorial
region of the sperm head and the epithelium of epididymal tubule. Although RNase9 belongs to the
RNase A family, it has no ribonuclease activity.
Background
The epididymis is a long, convoluted duct. As
immature spermatozoa move through the epididymis,
they are transformed into fully motile and fertile
sperm cells through sequential interactions with
proteins present in the luminal fluid of the epididymis
[1]. At least 200 proteins are present in the epididymal
l u m e n[ 2 ] ;h o w e v e r ,t h ein vivo function of most of
these proteins is unclear. Exploring the function of
these epididymal proteins will be necessary for a full
understanding of sperm maturation and potentially
will lead to the identification of new drug targets for
male contraception. RNase9 initially was identified in
mouse epididymis through in silico analysis of
expressed sequence tags (ESTs) in the UniGene library
collection. Later, Devor et. al. identified human RNase9
in the human genome assembly, but the function of
this gene is unknown and the characterization has yet
to be done.
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GENSCAN http://genes.mit.edu/GENSCAN.html, Gen-
ome Browser http://blast.ncbi.nlm.nih.gov/Blast.cgi,
SignalP3.0 http://www.cbs.dtu.dk/services/SignalP, Pro-
file-Scan http://myhits.isb-sib.ch/cgi-bin/PFSCAN and
MacVector software were used in this study. The cDNA
fragment encoding the mature RNase9 peptide was
amplified from a human epididymis cDNA library that
we constructed [3]. With the following gene specific
primers: forward primer F 5'-TTGGTAC CGA CGA CGA
CGA CTG GTG CAG TTT CAA GAG GTG-3' (adds a KpnI
siteon its5'end)andthereverseprimerR5'-CCGGAATTC
TCC CCC GGG CTA GGG CGA TAT GA-3' (adds an EcoRI
site at the 3'end of the amplicon). The fragment was
s e q u e n c e da n di n s e r t e di n t ot h ep E T - 3 2 b( + )v e c t o rt h a t
encodes a His epitope tag (Novagen, Germany). Trans-
formed E. coli were grown to mid-log phase and fusion
protein expression was induced with 1 mM isopropyl-1-
thio-b-D-galactoside (IPTG) for 3 h at 37°C. Fractions
were analyzed on 15% SDS-polyacrylamide gels (SDS-
PAGE), and the molecular weight of RNase9 protein was
identified by MALDI-TOF. The recombinant protein was
purified by Ni
2+-affinity chromatography.
The tissue expression profiles of RNase9
Tissue samples (epididymis, heart, lung, liver, spleen,
kidney, stomach, testis, and muscle) were obtained from
individuals at different ages (fetus, adult, geriatric). All
samples were approved by the Ethics Committee of
Affiliated Yu-Huang-Ding Hospital of Qingdao University.
Total RNA was extracted with Trizol reagent (Invitrogen,
Carlsbad, CA) and 1 μg RNA was reverse transcribed using
20 U AMV Reverse Transcriptase (Promega, Beijing, China)
and 0.3 μg of oligo dT18 (Promega, Beijing, China)
according to the manufacturer's instructions. The human
RNase9 cDNA fragment was amplified with forward primer
F 5'-CTG GTG CAG TTT CAA GAG GTG-3'; reverse primer R
5'-TCCCCCGGG CTA GGGCGATATGA-3'.b-actin served
as an endogenous control and the primers sequences were
as follows: forward primer F 5'-CCA TGC CAA TCT CAT
CTT-3'; reverse primer R 5'-CGT GAC ATT AAG GAG AAG-
3'. The PCR reaction was carried out with Ex-Taq (TAKARA,
Japan) under the following conditions: 30 s at 95°C, 40 s at
56°C (RNase9)/49°C (b-actin), and 1 min at 72°C.
Immunolocalization of RNase9 in spermatozoa
Human semen samples were collected after three days of
sexual abstinence from normal fertile donors at 30 years
of age. Testicular sperm was isolated using 52% isotonic
Percoll (Amersham Bioscience) and resuspended in PBS
[4]. Epididymal sperms were recovered from the corpus
and caudal regions of the epididymis by puncture of the
ductuli and the sperm drops were flushed with PBS
containing 1 mM phenylmethylsulfonylfluoride (PMSF).
Sperm smears then were blocked with 3% BSA in PBS
(PBS-BSA, w/v) for 60 min at room temperature and
subsequently incubated overnight at 4°C with human
RNase9 antiserum (1:400). Parallel smears incubated
with mouse non-immune serum served as a negative
control. After three washes with PBS, smears were
incubated for 60 min at room temperature with
fluorescein isothiocyanate (FITC)-conjugated goat anti-
mouse IgG (1:200). Samples were washed in PBS,
counterstained with propidium iodide (PI, Invitrogen),
and then imaged with a laser scanning confocal
microscope (Carl Zeiss, META 510).
Immunolocalization of RNase9 in epididymis and testis
Frozen epididymis and testis were cut into serial 8 μm-
thick sections on a Reichert-Jung cryomicrotome and
mounted on poly L-lysine-coated slides. The sections
were freeze-dried and fixed with 4% paraformaldehyde
for 20 minutes. The samples then were permeabilized for
30 minutes with 0.5%Triton X-100in PBS.Subsequently,
tissue sections were blockedf o r6 0m i n u t e sw i t h3 %B S A
(w/v) in PBS at room temperature and incubated over-
night at 4°C with polyclonal anti-RNase9 serum (1:400).
AfterseveralwasheswithPBS,thesectionswereincubated
for 60 minutes at room temperature with FITC-con-
jugated goat anti-mouse IgG (1:200). As a negative
control, serial sections were processed with the same
procedure but pre-immune serum was used as primary.
Afterthreewasheswithdeionizedwater,thesections were
mounted and examined with aconfocal microscope (Carl
Zeiss, META 510).
Ribonuclease activity assay
RNase9 (20 nmol) was incubated with 1.42 nmol of a
standard yeast tRNA substrate in 40 mM sodium
phosphate buffer (pH 7.4) at 25°C. The reaction was
terminated by the addition of 0.5 ml of 20 mM
lanthanum nitrate with 3% perchloric acid, and the
insoluble tRNA was removed by centrifugation. The
amount of solubilized tRNA was determined by ultravio-
let absorbance at 260 nm. Catalytic activity was expressed
as pmol of RNA digested in 1 sec by 1 pmol of RNase9.
Recombinant protein HEL-75 (with no RNase activity)
was used to control for bacterial RNase contamination
[5]. Three independent experiments were conducted.
Sperm motility assay and zona-free hamster egg
penetration test
Spermatozoa were incubated with RNase9 antiserum
(1:200) at 37°C in 5% CO2 for two hrs and then evaluated
for motility using the computer-aided sperm analysis
(CASA) system. Sperm penetration was determined by the
presence of a swollen sperm head within the cytoplasm of a
zona pellucida-free hamster egg. The penetration index was
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number inseminated [6]. For two groups of data, two-tail
Student's tests were used. A probability of P < 0.05 was
ceonsidered to be statistically significant.
Results
The RNase9 gene is located on human chromosome
14q11.2 [GenBank: NT-026437], along with the twelve
known members of the RNase A family (Figure 1).
RNase9 was predicted to encode a protein of 205 amino
acids. The first 26 amino acids of RNase9 were identified
a putative signal peptide by SignalP3.0 software. After
cleavage of the signal peptide, the mature RNase9
protein was 179 amino acids in length, with a pI of
5.92. At the amino acid level, RNase9 was 15% ~ 30%
identical to the canonical RNase A members (RNase 1 –
8). Functional sites on the protein were predicted using
the software, Profile-Scan http://myhits.isb-sib.ch/cgi-
bin/PFSCAN. Two potential N-glycosylation sites were
predicted at N131RSK and N143LTE; three N-myristoy-
lated sites were predicted at G74MPLNH, G126IRKCN,
and G135LVEGV. In addition, two potential post-transla-
tional phosphorylation modification sites were present
in this sequence, including two casein kinase II
phosphorylation sites, T31DFD and T181IND, and one
tyrosine kinase phosphorylation site, Y141. The sequence
also contains a potential Big-1 (bacterial Ig-like) domain
at L23VQFQ (Figure 2).
We prepared the recombinant RNase9 protein through a
fusion expression strategy (Fig. 3A). The fusion tag can be
released easily with the enterokinase site fused between
the tag and target protein. SDS-PAGE and MALDI-TOF
showedthemassofRNase9proteinwas19kD,consistent
with the theory (Fig. 3B, C). Western blot analysis also
indicated that the natural RNase9 protein was slightly
larger than the recombinant RNase9. RNase9 was
expressed in all tissues (epididymis, heart, lung, liver,
spleen,kidney,stomach,andtestis)exceptmuscle(Figure
4A). Furthermore, expression of RNase9 was higher in
adults than in elderly men or boys (Figure 4B). Indirect
immunofluorescence staining showed that RNase9 pro-
tein was localized predominantly to the post-equatorial
region of the sperms' head: approximately 80% of the
epididymal and ejaculated spermatozoa were positive
(Figure 5). RNase9 protein signal was detected in the
epithelial cells of the epididymal tubule and no fluores-
cence was detected in the testis (Figure6). RNase9 protein
had no detectable RNase activity towards yeast tRNA
Figure 1
Diagram of human chromosome 14q11.2. A 550-kb
region of chromosome 14q11.2 containing all 13 members of
t h eR N a s eAg e n ef a m i l yi ss h o w n .T h er e l a t i v es p a c i n go f
RNase9 within the RNase A family, as well as their
transcription orientations also is shown.
Figure 2
The cDNA and amino acid sequences of human
RNase9. The open reading frame contains 618 bp and
encodes a 205-amino acid protein. The initial and terminal
codons are boxed. The protein contains a putative signal
peptide with a cleavage site between L23 (star) and V24.
Predicted N-glycosylation sites (at N131 and N143;
underscored), casein kinase II phosphorylation sites,
(T31DFD and T181IND; circled), N-myristoylation sites
(G74MPLNH, G126IRKCN, and G135LVEGV; solid triangles),
and a tyrosine kinase phosphorylation site (KGLVEGVY141,
open triangles) are shown. The location of the putative Big-1
domain (L23VQFQ; star) and the pancreatic ribonuclease
(shaded) also are shown.
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Identification of rRNase9 and western blot results. A:
Strategy for expressing RNase9 protein as a Trx fusion in E.
coli;B :( a )S D S - P A G E .1 .T r x - r R N a s e 9 ;2 .r R N a s e 9 ;( b )
Western blot 1.Trx-rRNase9; 2. rRNase9; 3. RNase9 in
epididymal fluid. C: MALDI-TOF analysis of rRNase9.
Figure 4
Expression of RNase9 (A) Tissue distribution of
RNase9. The indicated tissues were analyzed for RNase9
mRNA levels (550 bp) by RT-PCR. RNA (2 ug) from various
tissues and different parts of the human epididymis was
reverse-transcribed and analyzed by RT-PCR.RNase9 was
expressed in all the tissues: epididymis, heart, lung, liver,
spleen, kidney, stomach, and testis except muscle (negative
control). b-actin (580 bp) served as an internal control. (B)
RNase9 expression in epididymis. RT-PCR analysis of RNase9
mRNA levels (550 bp) in human epididymal tissues. Human
epididymis tissues were collected from fetus, adult, and older
individuals. b-actin (580 bp) served as an internal control.
Figure 5
Immunofluorescence staining of RNase9 in
spermatozoa. A1~C1: phase contrast image; A2~C2
nuclear counterstain (PI); A3: Ejaculated sperm; B3:
Epididymal sperm; C3: Testicular sperm; A4~C4: Merged
image; Green staining indicates the immunofluorescence of
human RNase9 (FITC-labeled); Red staining (PI) indicates the
nuclei. Scale bar: 5 μm.
Figure 6
Immunofluorescence staining of RNase9 in
epididymis and testis. A ,B :e p i d i d y m i st i s s u e ;C ,D :t e s t i s
tissue; B, D: negative control. 1: phase contrast image; 2:
nuclear counterstain (PI); 3: Green immunofluorescence
staining of human RNase9 (FITC-labeled); 4: Merged image.
Scale bar: 50 μm
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under the same experimental conditions with the same
amount of substrates in order to obtain a direct
comparison. Meanwhile, we used the recombinant HEL-
75 protein as a control to eliminate the possibility of
contamination by bacterial RNase. Comparing the two
group spermatozoa that were blocked with RNase9 anti-
serum and pre-immune serum respectively, there was no
significant difference in motility and fertility of sperm (p
> 0.05) (Table 2, Figure 7).
Discussion
A large number of genes have been identified with the
advance of technology, but human epididymis studies
are constrained by the impracticality of experimentation
and by the advanced age of available tissue donors. To
overcome these difficulties, we constructed a normal
adult human epididymis cDNA library[3] and cloned
RNase9.H u m a nRNase9 share homology with mice, rats,
monkeys, and chimpanzees and belongs to the RNase A
family. However, RNase9 lacks the conserved catalytic
triad and the family's signature motif (CKXXNTF) [7].
This may explain the loss of ribonucleic activity with
purified RNase9 protein. In addition, RNase9 was found
to have a pI that is lower than that of other RNase A
family members. The relatively high pI of typical RNases
is thought to be important for their ribonucleic activity,
since the positive charge increases the affinity of the
enzyme to the negatively charged RNA substrate [8].
Previous studies showed that most RNase genes are
expressed in a wide range of tissues except for RNase 3
and RNase 8, which are expressed prominently in
eosinophils and placenta, respectively [9, 10]. Likewise,
human RNase9 also is expressed in many tissues. In
contrast, rat RNase9 is located on chromosome 15 and
expression was localized to the epididymis. There are no
other reports about RNase9 at present.
In the sperm, the postacrosomal region or equatorial
segment is involved in sperm-egg plasma membrane
fusion. Indirect immunofluorescence demonstrated that
the RNase9 protein is expressed on the post-equatorial
region of the sperm head. Taken together with our RT-
PCR results and immunofluorescence staining results,
these findings suggest that the RNase9 protein is
synthesized maily by the epididymis and always binds
to the surfaces of epididymal and ejaculated spermato-
zoa. We know that the sperm membrane undergoes
substantial remodeling to induce sperm maturation
during epididymal transit and many epididymal proteins
take part in this process. Further study into the actual
roles of RNase9 protein is needed.
Many proteins in the epididymis are androgen-regulated,
such as b-defensin 118 (DEFB118), cystatin-related
epididymal specific (CRES) protein, disintegrin and
metalloprotease (ADAMs) [11, 12]. Rat RNase9i sa l s o
androgen dependent. At present, the relationship
between human RNase9 and androgens is unknown
and the castration test is limited by experimental
conditions, but RT-PCR results in different individuals
Figure 7
Zona-free hamster egg penetration test. In vitro
fertilization test, the total number of eggs tested was 60(A
group) and 62 (B group), respectively. Fertility rate has no
significant difference between A (50 of 60, 83%) and B (48 of
62, 77%) group, **p > 0.05. A: Sperm blocked with pre-
immune serum (1:200) for 5 h as control; B: Sperm blocked
with RNase9 anti-serum (1:200) for 5 h.
Table 2: Motility parameters analysis of sperm
Parameters A B
VAP(um s-1) 33.80 ± 0.97 36.31 ± 1.52*
VSL(um s-1) 33.34 ± 1.11 30.82 ± 1.89*
VCL(um s-1) 48.19 ± 1.07 45.75 ± 0.86*
N = 10. Data were obtained by using computer assisted sperm analysis
and are expressed as mean ± SEM. *p > 0.05. A: Sperm blocked with
pre-immune serum (1:200) for 5 h as control; B: Sperm blocked with
RNase9 anti-serum(1:200) for 5 h. VAP, avaraged path velocity; VSL,
straight line velocity; VCL, curvilinear velocity.
Table 1: Ribonuclease activity
Enzyme Activities* ± SD
RNase1 0.167 ± 0.002
†
RNase9 0.011 ± 0.007
†
HEL-75 0.002 ± 0.001
†
*Ribonuclease activities were measured as pmol RNA digested per pmol
enzyme per second.
†Value represents the mean of three independent
experiments.
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highest in adults. Whether the expression of RNase9 is
androgen-regulated is not known and requires further
study. Additional approaches are under development to
analyze the reproductive biology in RNase9 knockout
animal models.
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